Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
Recruiting
Phase 4
Interventional Study
Dental Pain and Sensation Disorder
Pain, Postoperative
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 59
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 98 (estimated)
- Sponsor
- Loma Linda University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a double-blind, randomized, prospective, placebo-controlled single-center clinical research study in which 600 mg of gabapentin or placebo will be administered 2 hours preoperatively to 49 patients each undergoing wisdom teeth extraction. We will measure intraoperative opioid use, severity of pain, the number of analgesics taken, and side effect profiles (e.g. nausea/vomiting, dizzin…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects must be at or older than 18.
* Screened body mass index (BMI) between 18-35 kg/m2.
* American Society of Anesthesiologists Classification I and II.
* Subjects must be willing and able to comply with protocol requirements.
* Subjects must be able to understand the info…
Contacts